These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37942138)

  • 41. Multi-domain interventions for the prevention of dementia and cognitive decline.
    Hafdi M; Hoevenaar-Blom MP; Richard E
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013572. PubMed ID: 34748207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
    Shen J; Amari N; Zack R; Skrinak RT; Unger TL; Posavi M; Tropea TF; Xie SX; Van Deerlin VM; Dewey RB; Weintraub D; Trojanowski JQ; Chen-Plotkin AS
    Ann Neurol; 2022 Aug; 92(2):255-269. PubMed ID: 35593028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
    Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
    J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.
    Lichter DG; Benedict RHB; Hershey LA
    J Parkinsons Dis; 2018; 8(4):539-552. PubMed ID: 30124451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
    Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
    J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are Standardized Tests Sensitive to Early Cognitive Change in Parkinson's Disease?
    Turner TH; Lench DH; Adams R; Wilson S; Marsicano C; Rodriguez-Porcel F
    Psychopharmacol Bull; 2023 Feb; 53(1):19-29. PubMed ID: 36873920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies.
    Guo Y; Xu W; Liu FT; Li JQ; Cao XP; Tan L; Wang J; Yu JT
    Mov Disord; 2019 Jun; 34(6):876-883. PubMed ID: 30869825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of cognitive impairment in newly diagnosed Parkinson's disease with normal cognition at baseline: A 5-year cohort study.
    Chen J; Zhao D; Wang Q; Chen J; Bai C; Li Y; Guo X; Chen B; Zhang L; Yuan J
    Front Aging Neurosci; 2023; 15():1142558. PubMed ID: 36926634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is the Random Forest Algorithm Suitable for Predicting Parkinson's Disease with Mild Cognitive Impairment out of Parkinson's Disease with Normal Cognition?
    Byeon H
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting Cognitive Decline in Parkinson's Disease with Mild Cognitive Impairment: A One-Year Observational Study.
    Chen PH; Cheng FY; Cheng SJ; Shaw JS
    Parkinsons Dis; 2020; 2020():8983960. PubMed ID: 33178412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.
    Vos SJB; van Boxtel MPJ; Schiepers OJG; Deckers K; de Vugt M; Carrière I; Dartigues JF; Peres K; Artero S; Ritchie K; Galluzzo L; Scafato E; Frisoni GB; Huisman M; Comijs HC; Sacuiu SF; Skoog I; Irving K; O'Donnell CA; Verhey FRJ; Visser PJ; Köhler S
    J Alzheimers Dis; 2017; 58(2):537-547. PubMed ID: 28453475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease.
    Martínez-Horta S; Bejr-Kasem H; Horta-Barba A; Pascual-Sedano B; Santos-García D; de Deus-Fonticoba T; Jesús S; Aguilar M; Planellas L; García-Caldentey J; Caballol N; Vives-Pastor B; Hernández-Vara J; Cabo-Lopez I; López-Manzanares L; González-Aramburu I; Ávila-Rivera MA; Catalán MJ; López-Díaz LM; Puente V; García-Moreno JM; Borrué C; Solano-Vila B; Álvarez-Sauco M; Vela L; Escalante S; Cubo E; Carrillo-Padilla F; Martínez-Castrillo JC; Sánchez-Alonso P; Alonso-Losada MG; López-Ariztegui N; Gastón I; Blázquez-Estrada M; Seijo-Martínez M; Rúiz-Martínez J; Valero-Merino C; Kurtis M; de Fábregues-Boixar O; González-Ardura J; Prieto-Jurczynska C; Martinez-Martin P; Mir P; Kulisevsky J;
    BMC Neurol; 2021 Dec; 21(1):477. PubMed ID: 34879838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    Ffytche DH; Pereira JB; Ballard C; Chaudhuri KR; Weintraub D; Aarsland D
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):325-331. PubMed ID: 28315846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures.
    Kim HM; Nazor C; Zabetian CP; Quinn JF; Chung KA; Hiller AL; Hu SC; Leverenz JB; Montine TJ; Edwards KL; Cholerton B
    Clin Park Relat Disord; 2019; 1():91-97. PubMed ID: 32368733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
    Goldman JG; Ghode RA; Ouyang B; Bernard B; Goetz CG; Stebbins GT
    Parkinsonism Relat Disord; 2013 Sep; 19(9):806-11. PubMed ID: 23735187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The epidemiology of cognitive function in Parkinson's disease.
    Bock MA; Tanner CM
    Prog Brain Res; 2022; 269(1):3-37. PubMed ID: 35248199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.